Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

BACKGROUND: The objective of this study was to report on the long‐term effects of pexidartinib on tenosynovial giant cell tumor (TGCT). METHODS: This was a pooled analysis encompassing 3 pexidartinib‐treated TGCT cohorts: 1) a phase 1 extension study (NCT01004861; 1000 mg/d; n = 39), 2) ENLIVEN pati...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer
Main Authors: Gelderblom, Hans, Wagner, Andrew J., Tap, William D., Palmerini, Emanuela, Wainberg, Zev A., Desai, Jayesh, Healey, John H., van de Sande, Michiel A. J., Bernthal, Nicholas M., Staals, Eric L., Peterfy, Charles G., Frezza, Anna Maria, Hsu, Henry H., Wang, Qiang, Shuster, Dale E., Stacchiotti, Silvia
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2020
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7946703/
https://ncbi.nlm.nih.gov/pubmed/33197285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33312
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍